Treatment Responses with Long-Term Valbenazine in Patients with Tardive Dyskinesia

被引：0
|
作者：
Singer, Carlos
Comella, Cynthia
Marder, Stephen
Farahmand, Khodayar
Jimenez, Roland
机构：
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1663
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2023, 35 (01) : 3 - 3
  • [2] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. CNS SPECTRUMS, 2023, 28 (02) : 241 - 241
  • [3] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farah-Mand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 344 - 345
  • [4] Sustained Treatment Response with Long-Term Valbenazine in Patients with Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farahmand, Khody
    Jen, Eric
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. NEUROLOGY, 2023, 100 (17)
  • [5] Sustained Treatment Response With Long-Term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph
    Lindenmayer, Jean-Pierre
    Farahmand, Khodayar
    Siegert, Scott
    Dunayevich, Eduardo
    [J]. NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 344 - 345
  • [6] Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia
    Correll, Christoph U.
    Citrome, Leslie
    Singer, Carlos
    Lindenmayer, Jean-Pierre
    Zinger, Celia
    Liang, Grace
    Dunayevich, Eduardo
    Marder, Stephen R.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (04) : 353 - 361
  • [7] Long-term effects of valbenazine on tardive dyskinesia in patients with a mood disorder
    McIntyre, R.
    Nierenberg, A.
    Farahmand, K.
    Burke, J.
    Siegert, S.
    [J]. BIPOLAR DISORDERS, 2018, 20 : 116 - 116
  • [8] LONG-TERM COST-EFFECTIVENESS OF VALBENAZINE AND DEUTETRABENAZINE FOR TARDIVE DYSKINESIA
    Harrigan, K.
    Walton, S. M.
    Huang, S. P.
    Kumar, V. M.
    Chapman, R. H.
    Atlas, S. J.
    Agboola, F. O.
    Ollendorf, D. A.
    Touchette, D. R.
    [J]. VALUE IN HEALTH, 2018, 21 : S184 - S184
  • [9] A long-term, open-label study of valbenazine for tardive dyskinesia
    Lindenmayer, Jean-Pierre
    Verghese, Cherian
    Marder, Stephen R.
    Burke, Joshua
    Jimenez, Roland
    Siegert, Scott
    Liang, Grace S.
    O'Brien, Christopher F.
    [J]. CNS SPECTRUMS, 2021, 26 (04) : 345 - 353
  • [10] Long-Term Outcomes in Patients with Tardive Dyskinesia who Were Early Responders with Valbenazine
    Factor, S.
    Comella, C.
    Marder, S.
    Burke, J.
    Farahmand, K.
    Siegert, S.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S595 - S596
12345